Streetbeat News

Earnings

HTZ

Hertz Global Holdings Inc (NASDAQ:HTZ) stock fell after reporting mixed Q4 2023 results with a 7% revenue growth to $2.18 billion, surpassing expectations. However, it posted an adjusted EPS loss of $(1.36), missing the consensus loss of $(0.76). The company saw increased volume across various customer channels but faced challenges with its electric vehicle fleet and other costs. Despite these issues, CEO Stephen Scherr expressed confidence in the company's future performance improvements.

Portfolio Pulse from Anusuya Lahiri

February 06, 2024 | 2:24 pm

AUDC

AudioCodes shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:22 pm

ZENV

Zenvia Inc. (NASDAQ:ZENV) announced agreements to address its funding gap, including debt extension, renegotiation of earnouts, and issuance of shares to its CEO for investment. The company also introduced its EBITDA guidance for 2024, expecting between BRL 120 million and BRL 140 million. These measures aim to reduce cash outflow, improve debt terms, and align the balance sheet with business needs, supporting Zenvia's strategy to enhance its SaaS platform.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:18 pm

LLY

Eli Lilly and Co (NYSE:LLY) projects a 20% revenue increase for 2024, driven by strong demand for its diabetes and obesity drugs, Mounjaro and Zepbound. The company's shares rose 5.8% in pre-market trading after announcing fourth-quarter earnings, with revenues from new products like Mounjaro and Zepbound contributing significantly to a total quarterly revenue of $9.35 billion, surpassing analysts' expectations. Lilly's 2024 revenue is estimated to be between $40.4 billion and $41.6 billion, up from $34.1 billion in 2023.

Portfolio Pulse from Benzinga Neuro

February 06, 2024 | 2:15 pm

BG

Bunge (NYSE:BG) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts expecting an EPS of $2.81. Investors are hopeful for a beat on this estimate and positive guidance for future growth. Historically, Bunge's stock price has shown mixed reactions to earnings reports, with a slight drop following last quarter's beat. Over the past year, BG shares have declined by 9.26%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:02 pm

HLT

Hilton Worldwide Holdings (NYSE:HLT) is scheduled to release its quarterly earnings report on February 7, 2024. Analysts predict an EPS of $1.57. The company's past earnings performance shows mixed results with minor share price fluctuations following earnings announcements. Shares are currently trading at $193.67, reflecting a 31.5% increase over the last 52 weeks. Investors are keenly awaiting the report and guidance for future quarters.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:02 pm

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) is anticipated to release its quarterly earnings report on February 7, 2024, with an expected EPS of $1.15. Historical data shows the company has previously surpassed EPS estimates, leading to slight share price movements. Shares have increased by 35.57% over the last year, indicating a positive outlook among long-term investors. The upcoming earnings report and guidance will be crucial for investor sentiment.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:02 pm

MCK

McKesson (NYSE:MCK) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts expecting an EPS of $7.05. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares have risen 38.52% over the last 52 weeks, trading at $507.94 as of February 2. Investors are advised to pay attention to the earnings report and especially the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:02 pm

FOXA

Fox (NASDAQ:FOXA) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts expecting an EPS of $0.11. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $31.41, down 14.15% over the last year. Investors will be keenly watching for not just the earnings results but also the future guidance provided by the company.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:02 pm

UNICY

Unicharm (OTC:UNICY) is expected to report a Q4 2024 EPS of $-0.16 on February 7, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historical data shows mixed reactions to past earnings reports, with the last quarter's beat followed by a 4.58% drop in share price. Over the last year, UNICY shares have declined by 7.45%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 2:01 pm